… Greek exit from the euro kept investors wary of risk, with biotech counters and electronics component makers the main drags ..... points to 7,124.89, after opening up 0.17 percent. Biotech stocks shed 2.17 percent while electronics component makers …
By Spencer Knight : Buying a beat down biotech stock, such as Mannkind ( MNKD ), requires patience more than anything else; except for the obvious due diligence. Mannkind …
By David Fry ( ETF Digest ): In the mid-1980s discoveries in biotechnology were revealed and investors piled-into many new companies like Genentech and Amgen. But the technology was yet to produce profits …
By M.E. Garza : Recently considered biotech 's immunotherapy darling, shares of Dendreon Corporation ..... will likely take years to resolve and may hold it back from biotech -like margins. In the interim period, the competitive landscape …
LONDON (Reuters) - GlaxoSmithKline said it would not proceed with its $2.6 billion offer for Human Genome Sciences unless the U.S. biotechnology company dropped a "poison pill" shareholder rights plan imposed to block the deal.
… Kapitall : Interested in the high-growth prospects of the biotech industry? For a closer look at some interesting biotech names, we ran a screen. We began by screening the biotech sector for stocks with strong liquidity, with current ratios …
… insiders appear to believe the risks are worth it for the considerable upside potential in their high-risk, high-return biotech . Celsion has developed ThermoDox treatment therapy, which uses heat-sensitive nano-particles to precisely place cancer …
Genetic Technologies ( GENE ) +39% after the Aussie biotech releases a positive business update for BREVAGen, which is used to test for certain genetic variations that are associated with an increased risk of developing breast cancer. Post your comment!
… monthly average. With shares trading just north of $3, the one-year target of $7.50 and the role of diagnostics in the biotech sector becoming increasingly more important with the movement toward personalized medicine have made this speculative stock …
… dominate the benchmark, although biotechnology , medical-equipment, and ..... Group UNH and WellPoint WLP, biotech companies such as Amgen AMGN ..... drugmakers, given that pharma and biotech companies make up the lion ..... saving efforts. In pharma/ biotech , merger activity is continuing …